What Is Pain? What Causes Pain?

From the FMS Global News Desk of Jeanne Hambleton (UK) Courtesy of MedicalNewsToday.com Written by Christian Nordqvist The English word ‘pain’ probably comes from Old French (peine), Latin (poena – meaning punishment pain), or Ancient Greek (poine – a word more related to penalty), or a combination of all three. In medicine pain relates to [...]

FIBRO WHAT?

By Jeanne Hambleton © 2007 This weekend (8th September 2007) is the start of Fibromyalgia Awareness Week and I, for one, am pig sick of people saying “Fibro what?” when I tell them I have fibromyalgia. I rang a travel insurance company to explain why I was falling apart at the seams so they would [...]

Opioids for managing chronic non-malignant pain: safe and effective prescribing.

Kahan M, Srivastava A, Wilson L, Mailis-Gagnon A, Midmer D. Addiction Medical Service, St Joseph’s Health Centre, Toronto, Ontario, Canada. kahanm@stjoe.on.ca OBJECTIVE: To review the evidence on safe and effective prescribing of opioids for chronic non-malignant pain. QUALITY OF EVIDENCE: MEDLINE was searched using the terms “opioid effectiveness” and “adverse effects.” There is strong evidence [...]

Prevalence of Interpersonal Abuse in Primary Care Patients Prescribed Opioids for Chronic Pain.

Balousek S, Plane MB, Fleming M. Department of Family Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. BACKGROUND: Interpersonal abuse is associated with clinical problems including chronic pain disorders. OBJECTIVES: The objective of this study is to describe 30-day and lifetime prevalence of emotional, physical, and sexual abuse found in [...]

JRRD releases single-topic issue on pain and pain management

Effects of depression and pain severity on satisfaction in medical outpatients: Analysis of the Medical Outcomes Study, pg. 143 Patient satisfaction is a critical measure of healthcare quality. We performed this study to see how depression and pain severity affected patient satisfaction in medical outpatients. We analyzed data from the Medical Outcomes Study and found [...]

Narrative review: the pathophysiology of fibromyalgia.

1: Ann Intern Med. 2007 May 15;146(10):726-34. Abeles AM, Pillinger MH, Solitar BM, Abeles M. New York University School of Medicine, New York University Hospital for Joint Diseases, and New York Harbor Healthcare System, New York, New York 10003, USA. Primary fibromyalgia is a common yet poorly understood syndrome characterized by diffuse chronic pain accompanied [...]

Novel pharmacotherapy for fibromyalgia.

1: Expert Opin Investig Drugs. 2007 Jun;16(6):829-41. Wood PB, Holman AJ, Jones KD. Louisiana State University Health Sciences Center–Shreveport, Department of Family Medicine, Shreveport, LA 71130, USA. pwood@lsuhsc.edu Fibromyalgia is a common disorder that is characterized by chronic widespread pain, tenderness to light palpation, fatigue and sleep disturbances. The present lack of a well-accepted model [...]

Substance Use Disorders in a Primary Care Sample Receiving Daily Opioid Therapy

1: J Pain. 2007 May 10; [Epub ahead of print] .Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Department of Family Medicine, University of Wisconsin, Madison, Wisconsin. The primary goal of this paper was to present a comprehensive picture of substance use disorders in a sample of patients receiving opioid therapy from their [...]

FDA Announces Results of Investigation Into Illegal Promotion of OxyContin by The Purdue Frederick Company, Inc.

FOR IMMEDIATE RELEASE P07-85 May 10, 2007 Media Inquiries: 301-827-6242 Consumer Inquiries: 888-INFO-FDA Company Misrepresented Prescription Pain Reliever to Health Care Professionals The U.S. Food and Drug Administration’s (FDA) Office of Criminal Investigations (OCI) announced today that The Purdue Frederick Company, Inc. has agreed to pay more than $700 million to resolve criminal charges and [...]

BEMA Fentanyl demonstrates substantial transmucosal delivery

Contact: Bill Douglass bill@investorrelationsgroup.com BioDelivery Sciences Findings form a part of pending NDA for the treatment of breakthrough cancer pain findings form a part of pending NDA for the treatment of breakthrough cancer pain Morrisville, North Carolina, May 7, 2007 — BioDelivery Sciences International, Inc. (Nasdaq:BDSI) announced the results of a 12 subject, crossover study [...]